Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy

Authors

Eric Lazear, University of North Carolina at Chapel Hill
Reza Ghasemi, Washington University School of Medicine in St. Louis
Sarah M. Hein, Courier Therapeutics
John Westwick, Courier Therapeutics
Dan Watkins, Courier Therapeutics
Daved H. Fremont, Washington University School of Medicine in St. Louis
Alexander Sasha Krupnick, University of Virginia

Journal

OncoImmunology

Publication Date

2017

Volume

6

Issue

2

Inclusive Pages

e1265721

Document Type

Open Access Publication

DOI

10.1080/2162402X.2016.1265721

Rights and Permissions

Lazear E, Ghasemi R, Hein SM, Westwick J, Watkins D, Fremont DH, Krupnick S (2017) Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy. OncoImmunology, 6(2): e1265721 The Version of Scholarly Record of this Article is published in OncoImmunology 2017, available online at http://dx.doi.org/10.1080/2162402X.2016.1265721 © 2017 The Author(s). Published with license by Taylor & Francis Group, LLC© Eric Lazear, Reza Ghasemi, Sarah M. Hein, John Westwick, Dan Watkins, Daved H. Fremont, and Alexander Sasha Krupnick This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.

Recommended Citation

Lazear, Eric; Ghasemi, Reza; Hein, Sarah M.; Westwick, John; Watkins, Dan; Fremont, Daved H.; and Krupnick, Alexander Sasha, "Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy." OncoImmunology. 6, 2. e1265721. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5723